STAT

STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks

STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risksWorldPing

An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news